DrugDevelopment

Boehringer Ingelheim’s Survodutide Shows Strong Weight‑Loss Results in Late‑Stage Trial

AstraZeneca’s CEO Says AI Is Redefining How New Medicines Are Built

BPC‑157: The Scientist Who’s Ready to Talk Skeptics

A New Chapter for Squamous Cell Lung Cancer: Harmoni’s Breakthrough at ASCO 2026

Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur

Day 2 Highlights from ASCO 2026: Breakthroughs from BioNTech, Pfizer, Kelun, Merck and Insights by Dr. Eric Pazdur

A Glimmer of Hope: Rewriting the Future of Pancreatic Cancer Treatment

A New Dawn in Medicine: Kailera's Triple-G Drug Unveils Staggering Potential

Kyle Diamantas Shines as Acting FDA Commissioner, Winning Trust Across the Board

Immunovant's Batoclimab Shakes Up Arthritis Treatment Hopes with Promising Trial Data

A Great Divide: American Biotech Grapples with the Ascendant Chinese Pharma Sector

REGENXBIO's Rollercoaster Ride: A Tale of Two Gene Therapies

Hantavirus Treatments Are Within Reach, Yet Funding Gaps Threaten Lifesaving Breakthroughs

The FDA's Uphill Battle: Reclaiming Trust and Scientific Rigor in a New Era

Neurocrine Biosciences: A Biotech Balancing Stable Growth with a Bold, Risky Bet

Navigating the Dragon's Den: China's Evolving Role in Global Biotech

Oncolytics Biotech: Sharpening the Focus for a Potential Breakthrough

Unpacking Tomorrow's Cancer Fight: Key Insights from AACR 2026

A New Dawn for Pancreatic Cancer: Unpacking the Revolutionary Science from AACR 2026

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

Unlocking the Bacterial Front Door: A Breakthrough in Antimicrobial Research

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Clock's Ticking: Harmony Biosciences, Wakix's Horizon, and the Path Ahead

A Digital Pioneer Departs: Andrew Baum's Exit from Pfizer

Lilly's Strategic Gambit: Unpacking the Kelonia Therapeutics Partnership

The Unlocking of a Legend: How Science Finally Conquered KRAS, the 'Undruggable' Cancer Foe

A Significant Setback: Arcus Biosciences Halts Key Lung Cancer Trial with Gilead

Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance

ALX Oncology Strengthens Leadership, Welcomes Biotech Veteran Jeff Knight as Chief Development and Operating Officer

A New Era of Hope: Revolutionizing Pancreatic Cancer Treatment

A Game Changer? Allogene's 'Off-the-Shelf' CAR T Therapy Shows Stunning Promise in B-Cell Lymphoma

Telix and Regeneron Unite: A Groundbreaking Alliance for Radiopharmaceutical Innovation

A Major Boost for Alzheimer's and Parkinson's Research: Annovis Bio Secures $10 Million

The Biotech Tango: Why Merck Pumped the Brakes on Terns Pharmaceuticals' Acquisition

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

Avacta Marks Pivotal Moment: First Patient Dosed in AVA6103 Cancer Trial

Jasper Therapeutics Forges Ahead: A Deep Dive into 2025 Results and Future Horizons for Briquilimab

Scholar Rock's Journey: From Production Setback to Market Readiness – Why We're Still Bullish

A New Dawn Against Aging? Rubedo's RLS-1496 Shows Remarkable Promise in Eliminating 'Zombie Cells'